Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 days agoThe shot was also 68.4% effective against... analyst Myles Minter noted trial recipients of Pfizer's...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Scientists are testing vaccines to protect cows and people against bird flu
Temple Daily Telegram· 13 hours agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 5 days agoAll three have occurred since April 1. Two of the patients were in Michigan. A Moderna spokeswoman...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna wins second product approval with RSV vaccine
Market Watch· 4 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says
MedPage Today· 5 days agoReporting System (VAERS) revealed that there were 1.5 reports of GBS per 1 million doses administered of the GSK RSV vaccine (Arexvy), and 5 reports per 1 million doses administered ...